RESUMEN

Tetracycline destructases (TDases) are flavin monooxygenases which can confer resistance to all generations of tetracycline antibiotics. The recent increase in the number and diversity of reported TDase sequences enables a deep investigation of the TDase sequence-structure-function landscape. Here, we evaluate the sequence determinants of TDase function through two complementary approaches: (1) constructing profile hidden Markov models to predict new TDases, and (2) using multiple sequence alignments to identify conserved positions important to protein function. Using the HMM-based approach we screened 50 high-scoring candidate sequences in Escherichia coli, leading to the discovery of 13 new TDases. The X-ray crystal structures of two new enzymes from Legionella species were determined, and the ability of anhydrotetracycline to inhibit their tetracycline-inactivating activity was confirmed. Using the MSA-based approach we identified 31 amino acid positions 100% conserved across all known TDase sequences. The roles of these positions were analyzed by alanine-scanning mutagenesis in two TDases, to study the impact on cell and in vitro activity, structure, and stability. These results expand the diversity of TDase sequences and provide valuable insights into the roles of important residues in TDases, and flavin monooxygenases more broadly.

Asunto(s)

Antibacterianos , Tetraciclina , Tetraciclina/farmacología , Antibacterianos/farmacología , Antibacterianos/química , Tetraciclinas/farmacología , Oxigenasas de Función Mixta , Escherichia coli/química , Farmacorresistencia Microbiana , Flavinas

RESUMEN

Inactivation of tetracycline antibiotics by tetracycline destructases (TDases) remains a clinical and agricultural threat. TDases can be classified as type 1 Tet(X)-like TDases and type 2 soil-derived TDases. Type 1 TDases are widely identified in clinical pathogens. A combination therapy of tetracycline and a TDase inhibitor is much needed to rescue the clinical efficacy of tetracyclines. Anhydrotetracycline is a pan-TDase inhibitor that inhibits both type 1 and type 2 TDases. Here, we present structural, biochemical, and phenotypic evidence that anhydrotetracycline binds in a substrate-like orientation and competitively inhibits the type 1 TDase Tet(X6) to rescue tetracycline antibiotic activity as a sacrificial substrate. Anhydrotetracycline interacting residues of Tet(X6) are conserved within type 1 TDases, indicating a conserved binding mode and mechanism of inhibition. This mode of binding and inhibition is distinct from anhydrotetracycline's inhibition of type 2 TDases. This study forms the framework for development of next-generation therapies to counteract enzymatic tetracycline resistance.

Asunto(s)

Tetraciclina , Tetraciclinas , Tetraciclina/farmacología , Tetraciclinas/farmacología , Antibacterianos/farmacología , Antibacterianos/química

RESUMEN

Tetracyclines (TCs) are an important class of antibiotics threatened by an emerging new resistance mechanism─enzymatic inactivation. These TC-inactivating enzymes, also known as tetracycline destructases (TDases), inactivate all known TC antibiotics, including drugs of last resort. Combination therapies consisting of a TDase inhibitor and a TC antibiotic represent an attractive strategy for overcoming this type of antibiotic resistance. Here, we report the structure-based design, synthesis, and evaluation of bifunctional TDase inhibitors derived from anhydrotetracycline (aTC). By appending a nicotinamide isostere to the C9 position of the aTC D-ring, we generated bisubstrate TDase inhibitors. The bisubstrate inhibitors have extended interactions with TDases by spanning both the TC and presumed NADPH binding pockets. This simultaneously blocks TC binding and the reduction of FAD by NADPH while "locking" TDases in an unproductive FAD "out" conformation.

Asunto(s)

Compuestos Heterocíclicos , Tetraciclina , Tetraciclina/farmacología , Tetraciclina/metabolismo , NADP/metabolismo , Antibacterianos/farmacología , Antibacterianos/química , Tetraciclinas/farmacología , Inhibidores de la Síntesis de la Proteína , Oxidación-Reducción

RESUMEN

Diffusional quenching in isopentane (IP) glass at 77 K is demonstrated by the reduction of triphenylene phosphorescence lifetimes in the presence of 1,3-pentadiene and/or molecular oxygen. Fluorescence spectra and lifetimes of cis- and trans-1,2-di(1-methyl-2-naphthyl)ethene in IP glass at 77 K reveal that the cis → trans photoisomerization leads to the trapping of unstable conformers of the trans isomer. The claim that IP at 77 K is not sufficiently viscous to trap unstable photoproduct conformers is invalidated.